Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
This pooled cohort study clarifies the association between cumulative mean systolic blood pressure and incident stroke types and explores whether race and ethnicity modify these…
This Medical News article discusses approaches to slow the spread of antimicrobial resistance in Neisseria gonorrhoeae.
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
This cohort study compares response- and progression-based end points in clinical trial and observational cohorts of US patients with non–small cell lung cancer (NSCLC).
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…
This Medical News story discusses new USPSTF recommendations about the timing of screening mammograms.